Lv3
370 积分 2022-11-24 加入
A Phase 2b Multicenter Study to Evaluate Basmisanil as an Adjunctive Treatment in Patients With Cognitive Impairment Associated With Schizophrenia
5个月前
已完结
2025 FDA approvals
6个月前
已完结
Peripheral Neuropathy
7个月前
已完结
Combination therapy for kidney disease in people with diabetes mellitus
1年前
已完结
Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes
1年前
已完结
Efficacy and safety of EMA401 in peripheral neuropathic pain: results of 2 randomised, double-blind, phase 2 studies in patients with postherpetic neuralgia and painful diabetic neuropathy
1年前
已完结
Biopharma dealmaking in 2024
1年前
已完结
High-value rare disease R&D deals of 2021
1年前
已完结
De-risking rare disease acquisitions: a win–win–win for patients, biotech and investors
1年前
已完结
The rise of China’s pharmaceutical industry from 2015–2024: a decade of innovation
1年前
已完结
皖公网安备34019202002308
